Literature DB >> 16500783

Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.

Murat Colakoglu1, Guzin Fidan Yaylali, Nagihan Yalcin Colakoglu, Mustafa Yilmaz.   

Abstract

Standard treatments for visceral leishmaniasis (antimonials, amphotericin B and pentamidine) pose several problems. Failure of antimonials or severe toxicity is particularly troublesome in patients with renal insufficiency. We report a case of visceral leishmaniaisis and renal insufficiency successfully treated with fluconazole and allopurinol for 4 months.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16500783     DOI： 10.1080/00365540500321405

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  3 in total

1.  Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv.

Authors:  Nishi Shakya; Shraddha A Sane; Suman Gupta
Journal:  Parasitol Res       Date:  2011-01-07       Impact factor: 2.289

2.  Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs.

Authors:  Nishi Shakya; Preeti Bajpai; Suman Gupta
Journal:  J Parasit Dis       Date:  2011-05-20

3.  Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus-Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial.

Authors:  Ermias Diro; Koert Ritmeijer; Marleen Boelaert; Fabiana Alves; Rezika Mohammed; Charles Abongomera; Raffaella Ravinetto; Maaike De Crop; Helina Fikre; Cherinet Adera; Harry van Loen; Achilleas Tsoumanis; Wim Adriaensen; Asrat Hailu; Johan van Griensven
Journal:  Clin Infect Dis       Date:  2018-01-18       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.